Gestational choriocarcinoma: An unusual presentation with response to gemcitabine and surgery

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 111, Issue 4, 2004, Pages 382-384

  Pandian, Zabeena ^a   Seckl, Michael J ^a,b   Smith, Richard ^c   Lees, D A Russell ^d  

^a ABERDEEN MATERNITY HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^d RAIGMORE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; GEMCITABINE; METHOTREXATE; VINCRISTINE SULFATE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHORIOCARCINOMA; CLINICAL EXAMINATION; FEMALE; HUMAN; HYSTERECTOMY; LUNG METASTASIS; PREGNANCY; PRIORITY JOURNAL; BLOOD; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PREGNANCY COMPLICATION; PROGNOSIS; UTERUS CANCER;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CHORIOCARCINOMA; CHORIONIC GONADOTROPIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; HUMANS; HYSTERECTOMY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROGNOSIS; UTERINE NEOPLASMS;

EID: 1842609584     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00065x.x     Document Type: Article

References (9)

1. Seckl MJ, Newlands ES. Treatment of gestational trophoblastic disease [review]. Gen Diagn Pathol 1997;143(2-3):159-171.
2. Bower M, et al. EMA/CO for high risk gestational trophoblastic tumors: results from cohort of 272 patients. J Clin Oncol 1997;15(7):2636-2643.
3. Newlands ES, Mulhollan PJ, Holden L, Seckl MJ, Rustin GJ. Etoposide and cisplatin/etoposide, methotrexate and actinomycin (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors [comment]. J Clin Oncol 2000;18(4):854-859.
4. Jones WB, Schneider J, Shapiro F, Lewis Jr JL. Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases. Gynaecol Oncol 1996;61(1):126-130.
5. Newlands ES, Holden L, Seckl MJ, McNeish I, Strickland S, Rustin GJ. Management of brain metastases in patients with high-risk gestational trophoblastic tumours. J Reprod Med 2002;47(6):465-467.
6. Seckl MJ, Fisher RA, Salerno G, et al. Choriocarcinoma and partial hydatidiform moles [comment]. Lancet 2000;356(9239):1443-1444.
7. McNeish IA, Strickland S, Holden L, et al. Low risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992-2000. J Clin Oncol 2002;20(7):1838-1844.
8. Einhorn LH, Stender MJ, Williams SD. Phase II trial of gemcitabine in refractory germ cell tumours. J Clin Oncol 1999;17(2):509-511.
9. Bokemeyer C, Gerl A, Schoffski P, et al. Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol 1999;17(2):512-516.